June 2024

Requests that are not applicable to the Trust or those that have been transferred out are listed below;

CORP 2024 - 120 Functional Neurological Disorder

Freedom of Information Requests actioned by the Trust;

CORP 2024 - 110 Treatment for breast cancer
CORP 2024 - 110 Treatment for breast cancer (PDF, 269Kb)

CORP 2024 - 112 Voice, data & network
CORP 2024 - 112 Voice, data & network (PDF, 520Kb)

CORP 2024 - 113 Use of Insourcing
CORP 2024 - 113 Use of Insourcing (PDF, 231Kb)

CORP 2024 - 114 Treatment of Melanoma
CORP 2024 - 114 Treatment of Melanoma (PDF, 292Kb)

CORP 2024 - 115 Treatment of NSCLC
CORP 2024 - 115 Treatment of NSCLC (PDF, 276Kb)

CORP 2024 - 116 Job Planning and Appraisals
CORP 2024 - 116 Job Planning and Appraisals (PDF, 286Kb)

CORP 2024 - 117 Staff Bank and Rostering
CORP 2024 - 117 Staff Bank and Rostering (PDF, 321Kb)

CORP 2024 - 118 Agency and Direct Engagement
CORP 2024 - 118 Agency and Direct Engagement (PDF, 276Kb)

CORP 2024 - 119 Cancer Treatment using specified products
CORP 2024 - 119 Cancer Treatment using specified products (PDF, 266Kb)

CORP 2024 - 121 Treatment of Renal Cell Carcinoma
CORP 2024 - 121 Treatment of Renal Cell Carcinoma (PDF, 285Kb)

CORP 2024 - 122 Agency usage and spend
CORP 2024 - 122 Agency usage and spend (PDF, 278Kb)

CORP 2024 - 123 Clinical systems information request June 2024
CORP 2024 - 123 Clinical systems information request June 2024 (PDF, 447Kb)

CORP 2024 - 124 Speech and Language
CORP 2024 - 124 Speech and Language (PDF, 263Kb)

CORP 2024 - 125 FOI, SAR, PALS & Complaints data
CORP 2024 - 125 FOI, SAR, PALS & Complaints data (PDF, 279Kb)

CORP 2024 - 126 Gender reassignment and/or transgender guidance and policies
CORP 2024 - 126 Gender reassignment and/or transgender guidance and policies (PDF, 335Kb)